The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Biomarkers of Cardiovascular Disease as Risk Factors for Age-Related Macular Degeneration
Abstract
Purpose To measure and contrast 2 biomarkers of cardiovascular disease, C-reactive protein (CRP) and plasma homocysteine, in individuals with age-related macular degeneration (AMD) and control individuals without AMD.Design Case-control study.Participants Seventy-nine affected individuals and 77 unaffected individuals from the AMD Genetic Study Group returned to obtain CRP and homocysteine levels.Methods Both affected and unaffected individuals underwent testing for CRP and homocysteine. A detailed cardiovascular history was taken.Main outcome measures Mean CRP and homocysteine levels in affected and unaffected individuals.Results Mean CRP levels for affected and unaffected individuals were 3.42 and 2.30 mg/l, respectively (P = 0.03). Mean homocysteine levels for affected and unaffected individuals were 11.72 and 8.88 micromol/l, respectively (P<0.0001). In logistic regression models, older age, higher CRP, and higher homocysteine were risk factors for AMD. There were no significant differences between cases and controls in terms of gender, diabetes, hypertension, use of statin drugs, and smoking. The control group was significantly younger and had a lower rate of vitamin usage than the affected group.Conclusions Elevated CRP and homocysteine levels are associated with AMD and implicate the role of chronic inflammation and atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The association of cardiovascular disease and its risk factors with AMD have not been consistently reproduced (26, 127, 136, 153).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [153]
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
Graham, I. M., Daly, L. E., Refsum, H. M., Robinson, K., Brattström, L. E., Ueland, P. M., Palma-Reis, R. J., Boers, G. H., Sheahan, R. G., Israelsson, B., et al. (1997) · PubMed · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
Effect of Statin Therapy on C-Reactive Protein Levels
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,644
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Klein, R., Klein, R., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,382
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–160 of 160
A 76-Year-Old Man With Macular Degeneration
Arroyo, J. G. (2006) · JAMA · doi:10.1001/jama.295.20.2394 · Cited by 14
Genetic cardiovascular risk factors and age‐related macular degeneration
Haas, P., Aggermann, T., Steindl, K., Krugluger, W., Pühringer, H., Oberkanins, C., Frantal, S., & Binder, S. (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01697.x · Cited by 14
Min, J. K., Kim, J., & Woo, J. M. (2014) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2014.891755 · Cited by 15
Manresa, N., Mulero, J., Losada, M., & Zafrilla, P. (2015) · Retina · doi:10.1097/iae.0000000000000552 · Cited by 9
Effect of Photo-Mediated Ultrasound Therapy on Nitric Oxide and Prostacyclin from Endothelial Cells
Karthikesh, M. S., Wu, S., Singh, R., Paulus, Y. M., Wang, X., & Yang, X. (2022) · Applied Sciences · doi:10.3390/app12052617 · Cited by 9
Cardio-Ankle Vascular Index Elevation in Patients with Exudative Age-Related Macular Degeneration
Taniguchi, H., Shiba, T., Takahashi, M., Kanai, H., Hori, Y., Shirai, K., & Maeno, T. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.18796 · Cited by 8
Plasma antiphospholipid antibody levels in age-related macular degeneration
Özkan, B., Karabas, L. V., Altıntaş, Ö., Tamer, G. S., Yüksel, N., & Çağlar, Y. (2012) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2012.03.016 · Cited by 8
Žaliūnienė, D., Paunksnis, A., Gustienė, O., Braždžionytė, J., & Žaliūnas, R. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700609 · Cited by 8
Wysokiński, D., Synowiec, E., Chmielewska, M., Woźniak, K., Zaraś, M., Skłodowska, A., Błasiak, J., Szaflik, J., & Szaflik, J. P. (2011) · Medical Science Monitor · doi:10.12659/msm.881906 · Cited by 7
Fernández‐Robredo, P., Recalde, S., Hernández, M., Zarranz‐Ventura, J., Molins, B., Casaroli-Marano, R. P., Adán, A., Sáenz-de-Viteri, M., & García‐Layana, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01862 · Cited by 7
Role of inflammation in the pathogenesis of age-related macular degeneration
Scholl, S., Kirchhof, J., & Augustin, A. J. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.51 · Cited by 7
Chou, R., Lee, C., Chong, L.-W., Chang, K., Lin, C., Yan, K.-S., Tsou, C., & Hsu, Y. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1594-4 · Cited by 7
Banda, N. K., Moreland, L. W., Deane, K. D., Simberg, D., Scheinman, R. I., Frank, R. M., Seifert, J. A., Accelerating Medicines Partnership (AMP) RA/SLE Network, Anolik, J., Tabechian, D., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-03589-1 · Cited by 5
Soheilian, R., Bonyadi, M. H. J., Moein, H.-R., Babanejad, M., Ramezani, A., Yaseri, M., & Soheilian, M. (2016) · International Ophthalmology · doi:10.1007/s10792-016-0373-6 · Cited by 4
Küçük, M. F., Ayan, A., Toslak, D., Süren, E., Yaprak, L., Çetinkaya, E., Erol, M. K., & Çoban, D. T. (2019) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-019-02109-1 · Cited by 4
C-reactive protein levels do not correlate with retinal artery occlusion but with atherosclerosis
Goldenberg‐Cohen, N., Cohen, Y., Monselise, Y., Eldar, I., Axer‐Siegel, R., Weinberger, D., & Kramer, M. (2008) · Eye · doi:10.1038/eye.2008.159 · Cited by 4
Oxidative Damage and Macular Degeneration
Khandhadia, S., Cree, A. J., & Lotery, A. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_171 · Cited by 4
Choroidal endothelial cell activation in age-related macular degeneration
Skeie, J. M. (2010) · doi:10.17077/etd.rqzkgl09 · Cited by 4
Purola, P. K. M., Koskinen, S., Kaarniranta, K., & Uusitalo, H. M. T. (2025) · Acta Ophthalmologica · doi:10.1111/aos.17444 · Cited by 3
The Role of Inflammation in Age-Related Macular Degeneration
Harris, J. M., & Wu, D. M. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000578 · Cited by 2
Hernández, M., Romero‐Vázquez, S., Recalde, S., Bezunartea, J., Moreno-Orduña, M., Belza, I., García‐Layana, A., Adán, A., Fernández‐Robredo, P., & Molins, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-16631-z · Cited by 2
Oxidative Stress and Systemic Changes in Age-Related Macular Degeneration
Brantley, M. A., Osborn, M. P., Cai, J., & Sternberg, P. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_18 · Cited by 2
High-sensitivity C-reactive protein and endothelin-1 in age-related macular degeneration
Ghorbanihaghjo, A., Javadzadeh, A., Rashtchizadeh, N., Argani, H., Masoodnia, S., & Nezami, N. (2009) · Journal of Men s Health · doi:10.1016/j.jomh.2009.10.003 · Cited by 2
Choo, B. J., Hwang, Y. H., Lee, J. H., & Kim, T. J. (2013) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2013.54.1.104 · Cited by 2
Inflammation in Age-Related Macular Degeneration: What is the Evidence?
Xu, H., & Forrester, J. V. (2008) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-69459-5_7 · Cited by 2
Paradigm of Susceptibility Genes in AMD and PCV
Riaz, M., & Baird, P. N. (2017) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-4-431-56511-6_14 · Cited by 2
Curriculum Vitae Personal Data
Selmeczi, D. (2008) · Cited by 2
Investigation of pan-immune inflammatory value in patients with age-related macular degeneration
Meşen, S., & Yılmaz, M. N. (2026) · BMC Ophthalmology · doi:10.1186/s12886-026-04674-3 · Cited by 1
Plasma homocysteine and Endothelin-1 dysregulation: Insights into retinal endothelial dysfunction
Msa, M. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111118 · Cited by 1
Combined Therapies to Treat CNV in AMD: PDT + Anti-VEGF
Mataix, J., del Carmen, M., Palacios, E., & Nave, A. (2012) · InTech eBooks · doi:10.5772/31444 · Cited by 1
Proteomic Biomarkers for Age-Related Macular Degeneration
Crabb, J. W. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0022 · Cited by 1
Age-related macular degeneration treatment: current view (literature review)
Kalesinskaitė, M., Uljanionok, D., & Liutkevičienė, R. (2014) · Medicinos teorija ir praktika · doi:10.15591/mtp.2015.006 · Cited by 1
Serum Homocysteine Levels in Pseudoexfoliative Glaucoma and Primary Open Angle Glaucoma
Amoli, F. A., Ghobadi, A., & Fakhraie, G. (2012) · Iranian Journal of Ophthalmology · Cited by 1
Animal Models of Age-Related Macular Degeneration
Zeiss, C. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00005-1 · Cited by 1
Vishwanathan, R., & Johnson, E. J. (2012) · Wiley eBooks · doi:10.1002/9781119946045.ch56 · Cited by 1
Sun, D. K. (2015) · UA Campus Repository (The University of Arizona)
Seguridad sistémica del tratamiento anti-VEGF
Cabrera, L. F. (2010) · Elsevier eBooks · doi:10.1016/b978-84-8086-706-1.50022-5
Li, Y. (2015) · ScholarlyCommons (University of Pennsylvania)
Biomarkers for Age-Related Macular Degeneration
Gu, J. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Williams, L. (2008) · ProQuest Demo Repository
Pharmacologic Treatment of Atrophic Age Related Macular Degeneration: An update
Gupta, R., Azad, S. V., Dave, A., Singh, H. I., & Tinwala, S. I. (2012) · Delhi Journal of Ophthalmology · doi:10.4103/0972-0200.376609
Lecleire-Collet, A., Pâques, M., Girmens, J., Conrath, J., Gaudric, A., Sahel, J., & Massin, P. (2007) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(07)89685-9
da Silva, A. S. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-03022010-092312
Age-related macular degeneration: histopathological and serum autoantibody studies
Cherepanoff, S. (2007) · The Sydney eScholarship Repository (The University of Sydney)
Genetic and modifiable risk factors for age-related macular degeneration
Wang, J. J. (2006) · Expert Review of Ophthalmology · doi:10.1586/17469899.1.2.181
Imamura, Y., Ishida, S., & Tsubota, K. (2006) · Inflammation and Regeneration · doi:10.2492/inflammregen.26.492
Nutritional Supplement Use and Age-Related Macular Degeneration
Lo, A., & Yeung, I. Y. L. (2012) · InTech eBooks · doi:10.5772/33893
Asymmetric dimethylarginine and homocysteine in exudative age-related macular degeneration
Javadzadeh, A., Ghorbanihaghjo, A., Mansouri, S., & Rashtchizadeh, N. (2015) · Journal of Analytical Research in Clinical Medicine · doi:10.15171/jarcm.2015.037
Asymmetric dimethylarginine and homocysteine in exudative age-related macular degeneration
Practitioner, G. (2015)
Epidemiology and Aetiopathogenesis of Age-Related Macular Degeneration
Landrum, J. T., & Nolan, J. (2013) · CRC Press eBooks · doi:10.1201/b15556-8
Börncke, F. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1170
Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00006-9
Al-Salem, J. A., Rauz, S., & Wallace, G. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00114-0
Metabolic Syndrome and its Relation with Eye Diseases: Mini-Review
Şekeroğlu, H. T., & Alikaşifoğlu, M. (2018) · Turkiye Klinikleri Journal of Ophthalmology · doi:10.5336/ophthal.2018-60022
Tratamiento combinado farmacológico en la DMAE exudativa: Más allá de la monoterapia antiangiogénica
Carilla, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-84-8086-706-1.50025-0
Gupta, A. (2021) · Egyptian Journal of Ophthalmology · doi:10.21608/ejomos.2021.75761.1019
Epidemiology and Aetiopathogenesis of Age-Related Macular Degeneration
Sivaprasad, S., & Hykin, P. (2013) · CRC Press eBooks · doi:10.1201/b15556-4
Wallace, G. R., Rauz, S., & Parekh, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00017-9
Impact of Oxidized Lipids in the pathogenic mechanism of Age-Related Macular Degeneration
Angayarkanni, N., Babu, K. A., Raman, R., & Biswas, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00046-4
Battu, P., Sharma, S., Singh, R., & Anand, A. (2026) · Biomarkers in Medicine · doi:10.1080/17520363.2026.2677199
Metadata
- Authors
- Vine, A. K., Stader, J., Branham, K., Musch, D. C., & Swaroop, A.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Vine, Andrew K.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 112
- Issue
- 12
- Pages
- 2076-2080
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2061671127
- Cited by
- 160
- References
- 54
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 9 · 2012: 15
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- age-related macular degeneration, C-reactive protein, homocysteine, cardiovascular biomarkers, chronic inflammation, atherosclerosis, risk factors
- MeSH terms
- Aged, Aged, 80 and over, C-Reactive Protein, Chromatography, High Pressure Liquid, Female, Fluorescein Angiography, Homocysteine, Humans, Inflammation, Macular Degeneration, Male, Middle Aged, Nephelometry and Turbidimetry, Risk Factors, Biomarkers, Case-Control Studies, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review